Chagas disease, a parasitic illness primarily linked to South and Central America, is becoming more common in the United States, especially in California, where health officials are raising concerns. Recently published research in the CDC’s journal, Emerging Infectious Diseases, highlights human cases of Chagas disease confirmed in eight states. This has led experts to propose that it be officially recognized as “endemic” in certain parts of the U.S.
The Centers for Disease Control and Prevention (CDC) defines an endemic disease as one that consistently exists within a specific area. Dr. Marc Siegel, a senior medical analyst at Fox News, noted that while Chagas disease has been a known issue in the Southern U.S., it is now becoming more prevalent due to the presence of triatomine bugs, commonly referred to as “kissing bugs.”
The transmission of Chagas disease occurs when the feces of these infected bugs come into contact with a person’s body, often through a bite wound or mucous membrane. Dr. Norman Beatty, a lead author of the study, explained that the parasite enters the body when the bug defecates on the skin or mucous membranes while feeding.
Symptoms of Chagas include fever, fatigue, rashes, aches, and swollen lymph nodes, with more severe complications such as heart and digestive issues developing over time. The chronic phase of the disease can be deadly, affecting about 20% to 30% of those infected with serious heart problems or digestive issues, according to the CDC.
About 300,000 individuals in the U.S. have Chagas disease, primarily those who acquired it in Latin America. However, the actual number is unclear due to the absence of a national prevalence study. The disease is more common in areas where kissing bugs are found near human dwellings, particularly in states like California, Arizona, Texas, Louisiana, and Florida.
Dr. Beatty emphasized that many Americans remain unaware of Chagas disease and its transmission by these bugs. He advocates for increased public and healthcare provider education, as well as funding for research and monitoring programs. His team strives to raise awareness and push for more resources to protect at-risk communities.
Screening and treatment options are available, but many healthcare providers are not aware of the disease’s presence in certain communities. The U.S. has two approved antiparasitic drugs for Chagas disease treatment, Benznidazole and Lampit (nifurtimox), and a clinical trial is underway to evaluate a new treatment option.
There is currently no vaccine for Chagas disease, and patients in rural areas might struggle to find knowledgeable healthcare providers. Dr. Beatty noted that some individuals travel from other states to his clinic in Florida due to the lack of local care options.
Education is crucial for future clinicians to effectively test, treat, and manage Chagas disease. Dr. Beatty also shared preventive measures for keeping kissing bugs out of homes, emphasizing the importance of public awareness and education to combat this growing health threat.
